Hopeful of launching Covovax for adults in October this year, for children in Q1-2022, says Serum CEO
The Hindu
It will be a two-dose vaccine and the price will be decided at the time of launch, Adar Poonawalla added.
Serum Institute of India CEO Adar Poonawalla on Friday said he is hopeful that Covovax, another COVID-19 vaccine being manufactured by his company in India, will be launched in October for adults and for children by the first quarter of 2022. He also thanked the government for all the support provided to Serum Institute and said the company is always trying to expand its Covishield production capacity to meet the demand. Mr. Poonawalla met Home Minister Amit Shah in Parliament and the meeting between the two lasted for 30 minutes.More Related News

Tamil Nadu Assembly election 2026: TMC(M) gets five seats in NDA, to contest on BJP's 'Lotus' symbol
TMC(M) secures five NDA seats, to contest Assembly elections using BJP's 'Lotus' symbol in Tamil Nadu.

The Karnataka government will discuss with officials the possibility of creating a portal for unemployed youth to share their details and access job opportunities in micro, small and medium enterprises (MSMEs), Minister for Small Industries and Public Enterprises Sharanabasappa Darshanapur said in the Legislative Council on Tuesday.











